Syon Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
4,269
+1,835
+75% +$603K 0.06% 235
2025
Q4
$853K Sell
2,434
-11
-0.4% -$3.72K 0.04% 356
2025
Q3
$790K Sell
2,445
-1,723
-41% -$536K 0.04% 324
2025
Q2
$1.62M Sell
4,168
-10
-0.2% -$4.02K 0.11% 139
2025
Q1
$1.82M Buy
4,178
+480
+13% +$193K 0.15% 100
2024
Q4
$1.36M Buy
3,698
+49
+1% +$20.5K 0.12% 121
2024
Q3
$1.9M Buy
3,649
+13
+0.4% +$6.95K 0.17% 95
2024
Q2
$1.97M Buy
3,636
+104
+3% +$55K 0.18% 88
2024
Q1
$1.83M Sell
3,532
-2,906
-45% -$1.45M 0.17% 93
2023
Q4
$3.04M Buy
6,438
+3,980
+162% +$1.84M 0.13% 106
2023
Q3
$1.07M Buy
+2,458
New +$1.11M 0.13% 98

Other funds holding ELV

Syon Capital's ELV Position: Q1 2026 in Review

Syon Capital increased its Elevance Health (ELV) stake by 75% in Q1 2026, buying an estimated $603K and bringing the position to 4,269 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #235.

Syon Capital first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.04M in Q4 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Syon Capital held 4,269 shares of Elevance Health worth $1.25M as of Q1 2026.
  • Syon Capital bought 1,835 Elevance Health shares in Q1 2026, an estimated $603K.
  • Elevance Health made up 0.06% of Syon Capital's portfolio in Q1 2026, its #235 holding.
  • Syon Capital first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's Elevance Health position peaked at $3.04M in Q4 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.